Search

everythinglearnresearchcommunity

for

Search:↓

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Erdr1 could be a new marker for diagnosing hair loss.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Children with loose anagen hair have easily pluckable hair due to root sheath problems, and it might improve without treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia areata involves immune response and gene changes affecting hair loss.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Body hair transplantation is an effective method for restoring hair in people with severe baldness and limited scalp donor hair.